Companies/Quanterix Corporation

Company profile

Quanterix Corporation

NASDAQ: QTRX · Healthcare · Medical - Devices

PublicHQ Billerica, MACIK 0001503274Reports USD

#317 of 1,394 Healthcare companies by revenue44th-percentile growth

EA Score

55C

FH 52DQ 58GM 56SS 64

v0.1 · 65/100 weight · provisional

↑ workforce scale, balance-sheet leverage · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

$144.9M

Rev growth YoY (TTM)

+8.2%

Net income (FY)

-$107.2M

Employees

471

Market cap

$204.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$138.9M$138.9M2025

Net income-$107.2M-$107.2M2025

Operating income-$125.5M-$125.5M2025

Total assets$418.8M$418.8M2025

Liabilities$123.0M$123.0M2025

Equity$295.7M$295.7M2025

Revenue trend

FY2023 – FY2025 · USD

$79.7M

FY23

$105.5M

FY22

$28.5M

FY23

$59.3M

FY23

$90.8M

FY23

$122.4M

FY23

$137.4M

FY24

$138.9M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Product67%

Service And Other Revenue32%

License and Service1%

Grant0%

By geography

North America53%

EMEA31%

Asia Pacific16%

The read

Quanterix Corporation booked $138.9M in FY2025 revenue, growing 1.1% year over year — about the middle of the pack among Healthcare companies we track, at a -77.1% net margin.

Peers · Healthcare

Anika Therapeutics, Inc.74B InfuSystem Holdings, Inc.80B+High Tide Inc.——Profound Medical Corp.44D

Key facts

CEOEverett V. Cunningham

SectorHealthcare

IndustryMedical - Devices

HeadquartersBillerica, MA

ExchangeNASDAQ: QTRX

Employees471

IPO date2017-12-07

Latest filings

8-K2026-06-10 8-K2026-06-09 8-K2026-05-26 8-K2026-05-12 10-Q2026-05-06 8-K2026-05-06 DEF 14A2026-04-24 10-K2026-03-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.